iBio
IBIO
#10086
Rank
C$96.9 M
Marketcap
C$1.95
Share price
-0.71%
Change (1 day)
140.03%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): C-$1.06

According to iBio's latest financial reports the company's current EPS (TTM) is C-$1.04. In 2025 the company made an earnings per share (EPS) of C-$2.44 an increase over its 2024 EPS that were of C-$9.06.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.06-56.32%
2025C-$2.44-73.08%
2024C-$9.06-93.88%
2023C-$147.95-8.14%
2022C-$161.0692.67%
2021C-$83.60-80.33%
2020C-$424.95-35.11%
2019C-$654.85-38.96%
2018C-$1,073-6.1%
2017C-$1,14236.67%
2016C-$835.9733.33%
2015C-$626.9850%
2014C-$417.99-53.85%
2013C-$905.64-7.14%
2012C-$975.30-64.1%
2011C-$2,71777.27%
2010C-$1,533144.44%
2009C-$626.9812.93%
2008C-$555.2112.2%
2007C-$494.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.17-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
C-$0.72-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C-$11.73 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$0.24-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA